Date:
Location:
How are Cochrane Systematic Reiews used by the WHO? How do Cochrane contributors inform WHO guideline processes? What can Cochrane do better to increase uptake of its evidence in global public health policy?
These are just some of the questions that the cases presented in this session will address. Of interest to CoEds and others who are keen to increase the use of their hard work and share experiences!
1. Decision making by the Essential Medicines Committee: evidence, advocacy and access
The presenters will discuss the WHO Essential Medicines Committee’s considerations when reviewing applications. The case of Bevacizumab (Avastin) will be used to illustrate the prominent role a Cochrane review played in getting a medicine added to the Essential Medicines List for an off-label indication.
Nicola Magrini, Scientist, Essential Medicines and Health Products Department, WHO
Lisa Bero, Chair of Medicines Use and Health Outcomes at the University of Sydney, Australia and Co-Chair of the Cochrane Collaboration.
2. Developing the WHO sugars guideline: evidence, process and political influences
The presenters will discuss the process of developing the recently published WHO sugars guideline, how (Cochrane) evidence and expertise helped guide the process, as well as how other factors impacted the guideline development.
Chizuru Nishida, Coordinator
Nutrition Policy and Scientific Advice, Department of Nutrition for Health and Development, WHO
Joerg Meerpohl, Deputy Director, Cochrane Germany
3. Use of Cochrane evidence in guideline development: opportunities and challenges
Peter Olumese will present his views on the use of Cochrane expertise and systematic reviews in the WHO malaria guideline through a video. Following the video, Susan Norris will introduce the revised WHO Handbook for Guideline development (2nd Edition, 2014), and discuss how the revised Handbook may impact Cochrane contributors.
Peter Olumese, Medical Officer, Global Malaria Programme, WHO (by video)
Susan L. Norris, Secretary, Guidelines Review Committee, WHO